Literature DB >> 3989134

Effect of adenosine and adenosine-5'-triphosphate on atrioventricular conduction in patients.

S Favale, M Di Biase, U Rizzo, L Belardinelli, P Rizzon.   

Abstract

This study was carried out to further elucidate the effects of adenosine and adenosine-5'-triphosphate (ATP) on atrioventricular (AV) conduction in patients. Adenosine (0.24 mg/kg) and ATP (0.28 mg/kg) were administered intravenously to 37 patients undergoing intracardiac electrophysiologic evaluation. Both adenosine and ATP depressed AV conduction by lengthening the atrial to His bundle (AH) interval. The effects of adenosine and ATP after rapid intravenous bolus administration were fast in onset (15 +/- 0.5 and 15 +/- 1.5 s, respectively), but transient in duration (10.5 +/- 0.5 s for ATP and 17 +/- 3 s for adenosine). Although muscarinic blockade with 0.04 mg/kg atropine shortened the AH interval from a control value of 123 +/- 12 to 74 +/- 4 ms, it did not modify the effects of adenosine or ATP, or both (that is, latency and duration of the effects were not significantly different from before atropine administration). In contrast, aminophylline, a competitive antagonist of adenosine, completely prevented the effects of adenosine and ATP. Aminophylline alone also shortened the AH interval from a control value of 98 +/- 9 to 74 +/- 9 ms. This decrease was blocked by propranolol (0.1 mg/kg), whereas propranolol did not influence the ability of aminophylline to antagonize the effects of adenosine or ATP, or both. Thus, the catecholamines released by aminophylline are unlikely to account for the ability of aminophylline to antagonize the effects of adenosine and ATP. In conclusion, these findings indicate that intravenously administered adenosine and ATP are equally effective in producing AV block that is antagonized by aminophylline but not by atropine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989134     DOI: 10.1016/s0735-1097(85)80027-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

1.  Imaging of adenosine bolus transit following intravenous administration: insights into antiarrhythmic efficacy.

Authors:  G A Ng; W Martin; A C Rankin
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

Review 2.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

3.  [Cardiac effects of adenosine. Mechanism of action, pathophysiologic and clinical significance].

Authors:  M Böhm
Journal:  Klin Wochenschr       Date:  1987-06-01

4.  Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias.

Authors:  A C Rankin; K G Oldroyd; E Chong; A P Rae; S M Cobbe
Journal:  Br Heart J       Date:  1989-09

5.  Clinical features of adenosine sensitive syncope and tilt induced vasovagal syncope.

Authors:  M Brignole; G Gaggioli; C Menozzi; A Del Rosso; S Costa; A Bartoletti; N Bottoni; G Lolli
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

Review 6.  Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.

Authors:  D Faulds; P Chrisp; M M Buckley
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

7.  Acceleration of ventricular response to atrial flutter after intravenous adenosine.

Authors:  A C Rankin; A P Rae; A Houston
Journal:  Br Heart J       Date:  1993-03

8.  Adenosine induced transient cardiac standstill in catheter interventional procedures for congenital heart disease.

Authors:  J V De Giovanni; R A Edgar; A Cranston
Journal:  Heart       Date:  1998-10       Impact factor: 5.994

9.  Effects of adenosine on electrical activity of isolated guinea pig hearts.

Authors:  G Stark; F Sterz; U Stark; M Bachernegg; M Decrinis; A Lueger; E Pilger; H A Tritthart
Journal:  Basic Res Cardiol       Date:  1993 Jan-Feb       Impact factor: 17.165

10.  Therapeutic Targeting of Hypoxia-A2-Adenosinergic Pathway in COVID-19 Patients.

Authors:  Katarina Halpin-Veszeleiova; Stephen M Hatfield
Journal:  Physiology (Bethesda)       Date:  2021-09-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.